Algo storyFriendly circles are said to be at work in the Dolat Algotech stock over the last couple of months. Market chatter is that much of the recent interest has been coming from a cartel of Gujarat-based traders. Efforts to draw in retail investors to the party have not yielded fruit so far. In January, the stock had surged with a corresponding spike in trading volumes, but the rally soon fizz...

The Nifty remained mostly sideways on April 10 as investors chose to wait ahead of the US CPI inflation data, which could potentially impact rate cuts by the Fed. The resistance zone is placed at 22,700-22,750, while support is at 22,600.A decisive move above 22,750 might induce a rally towards 23,000 in the short term. Since the market appears to be rangebound, buying on dips and selling on ralli...

The Sensex and the Nifty started April 10 trade on a positive note, supported by gains in heavyweights, a day after the equity benchmarks hit record highs but failed to hold on to the gains.The Sensex was up 186.18 points, or 0.25 percent, at 74,869.88, and the Nifty was up 57.70 points, or 0.25 percent, at 22,700.5. The market breadth was in favor of gainers as around - 1,484 shares advanced, 705...

Cool bullsVoltas shares have been on a roll of late. Conviction in the stock seems to have gone up in the last couple of sessions after the company surprised the Street with a strong operating performance in the March quarter. The proprietary desk of the Pearl brokerage had been steadily accumulating stock for HNI clients over the last few months even as most analysts tracking the sector were skep...

The Sun Pharma Advanced Research Company stock has gained 40 percent this year against a 4 percent rise in the benchmark Nifty50Shares of Sun Pharma Advanced Research Company (SPARC) fell 5 percent to hit the lower circuit on April 10 after the Mumbai-based pharma company said it was abandoning the Phase 2 study on Vodobatinib for Parkinson's.The PROSEEK study was a global trial that enrolled 513 ...